New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
07:33 EDTATRSAntares Pharma'a Otrexup NDA accepted by FDA
Antares Pharma announced that the New Drug Application for Otrexup, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the FDA indicating that the application is sufficiently complete to permit a substantive review. Otrexup is being developed for self-administration of MTX to enhance the treatment of rheumatoid arthritis, poly-articular-course juvenile RA and psoriasis. The FDA has assigned a target date of October 14, ten months from the official NDA filing, to complete its review of the NDA.
News For ATRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
10:09 EDTATRSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:58 EDTATRSAntares Pharma initiated with an Outperform at JMP Securities
Target $4.
October 20, 2014
09:04 EDTATRSAdvanced Cell Technology names LeRoux Jooste as CCO
Subscribe for More Information
October 8, 2014
12:16 EDTATRSAntares Pharma management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use